News Medical11h
Gene editing shows promise for treating trisomy at cellular level
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
JD Supra11h
APHIS Reinstates Legacy Biotechnology Regulations: Implications for CRISPR-Edited Plants
USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...
sicklecellanemianews12h
1st SCD patient outside US receives gene-editing therapy Casgevy
An SCD patient in Bahrain received the gene-editing therapy Casgevy, marking the first time the treatment has been given outside the U.S.
PharmiWeb17h
Gene Editing Market: Comprehensive Analysis and Forecast 2025–2035
The global Gene Editing Market was valued at $5.1 billion in 2022 and is projected to reach $16.2 billion by 2030, growing at ...
Medindia21h
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US MANAMA, Kingdom of Bahrain, Feb ...